Abivax SA Sponsored ADR (ABVX) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Abivax has launched an At-The-Market (ATM) program on Nasdaq, allowing the company to raise up to $150 million by issuing American Depositary Shares (ADS) over the next three years. This strategic move is aimed at supporting its clinical programs and general corporate purposes, providing flexibility in its financing strategy. Piper Sandler & Co. will act as the sales agent, facilitating the sale of ADSs to eligible investors.
For further insights into ABVX stock, check out TipRanks’ Stock Analysis page.
